Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · IEX Real-Time Price · USD
1.400
-0.010 (-0.71%)
At close: Apr 19, 2024, 4:00 PM
1.380
-0.020 (-1.43%)
After-hours: Apr 19, 2024, 6:41 PM EDT

Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $68.65 million. The enterprise value is $42.88 million.

Market Cap 68.65M
Enterprise Value 42.88M

Important Dates

The next estimated earnings date is Monday, May 6, 2024, after market close.

Earnings Date May 6, 2024
Ex-Dividend Date n/a

Share Statistics

CRVS has 49.04 million shares outstanding. The number of shares has increased by 3.16% in one year.

Shares Outstanding 49.04M
Shares Change (YoY) +3.16%
Shares Change (QoQ) +0.16%
Owned by Insiders (%) 3.89%
Owned by Institutions (%) 39.96%
Float 34.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.77
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.04.

Current Ratio 4.07
Quick Ratio 3.96
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -59.60% and return on invested capital (ROIC) is -58.43%.

Return on Equity (ROE) -59.60%
Return on Assets (ROA) -50.60%
Return on Capital (ROIC) -58.43%
Revenue Per Employee n/a
Profits Per Employee -$965,321
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +28.44% in the last 52 weeks. The beta is 1.02, so CRVS's price volatility has been similar to the market average.

Beta (1Y) 1.02
52-Week Price Change +28.44%
50-Day Moving Average 1.95
200-Day Moving Average 1.86
Relative Strength Index (RSI) 28.91
Average Volume (30 Days) 199,090

Short Selling Information

The latest short interest is 1.40 million, so 2.85% of the outstanding shares have been sold short.

Short Interest 1.40M
Short Previous Month 1.49M
Short % of Shares Out 2.85%
Short % of Float 4.06%
Short Ratio (days to cover) 5.82

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -23.41M
Pretax Income -27.03M
Net Income -27.03M
EBITDA -26.88M
EBIT -27.03M
Earnings Per Share (EPS) -$0.56
Full Income Statement

Balance Sheet

The company has $27.15 million in cash and $1.37 million in debt, giving a net cash position of $25.78 million or $0.53 per share.

Cash & Cash Equivalents 27.15M
Total Debt 1.37M
Net Cash 25.78M
Net Cash Per Share $0.53
Equity / Book Value 38.68M
Book Value Per Share 0.79
Working Capital 21.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.94 million and capital expenditures -$34,000, giving a free cash flow of -$23.97 million.

Operating Cash Flow -23.94M
Capital Expenditures -34,000
Free Cash Flow -23.97M
FCF Per Share -$0.50
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.16%
Shareholder Yield -3.16%
Earnings Yield -39.37%
FCF Yield -34.91%

Analyst Forecast

The average price target for CRVS is $6.00, which is 328.57% higher than the current price. The consensus rating is "Buy".

Price Target $6.00
Price Target Difference 328.57%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -33.76%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2